amantadine has been researched along with Aura in 9 studies
amant: an antiviral compound consisting of an adamantane derivative chemically linked to a water-solube polyanioic matrix; structure in first source
| Excerpt | Relevance | Reference |
|---|---|---|
| "Literature searches were conducted utilizing PubMed and MEDLINE databases employing combinations of search terms including, but not limited to, "epilepsy", "refractory", "seizure", and the following medications: acetazolamide, amantadine, bumetanide, imipramine, lidocaine, verapamil, and various stimulants." | 4.95 | Outside the box: Medications worth considering when traditional antiepileptic drugs have failed. ( Perry, MS; Turner, AL, 2017) |
| "The authors administered to 18 children with an expressed pharmaco-resistant Lennox-Gastaut syndrome as adjuvant treatment medium doses of amantadine (Viregyt-K, Egyt), 8 mg/kg/day divided into 1-2 portions or L-DOPA (Nakom, Lek) 22 mg/kg/day in 3-4 portions." | 3.67 | [Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome]. ( Slapal, R; Zouhar, A, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (77.78) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 1 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Turner, AL | 1 |
| Perry, MS | 1 |
| Szakács, R | 1 |
| Weiczner, R | 1 |
| Mihály, A | 1 |
| Krisztin-Péva, B | 1 |
| Zádor, Z | 1 |
| Zádor, E | 1 |
| Gilbert, JC | 1 |
| Miras Portugal, MT | 1 |
| Aunis, D | 1 |
| Mandel, P | 1 |
| Warter, JM | 1 |
| Coquillat, G | 1 |
| Collard, M | 1 |
| Rohmer, F | 1 |
| Slapal, R | 1 |
| Zouhar, A | 1 |
| Mehta, VL | 1 |
| Bhalla, S | 1 |
| Wafai, ZA | 1 |
| Wallnöfer, H | 1 |
| Schiller, L | 1 |
| Florio, V | 1 |
1 review available for amantadine and Aura
| Article | Year |
|---|---|
Outside the box: Medications worth considering when traditional antiepileptic drugs have failed.
Topics: Amantadine; Anticonvulsants; Bumetanide; Central Nervous System Stimulants; Epilepsy; Humans; Imipra | 2017 |
8 other studies available for amantadine and Aura
| Article | Year |
|---|---|
Non-competitive NMDA receptor antagonists moderate seizure-induced c-fos expression in the rat cerebral cortex.
Topics: 4-Aminopyridine; Amantadine; Animals; Behavior, Animal; Cerebral Cortex; Dizocilpine Maleate; Dopami | 2003 |
Diseases of the central nervous system. Pharmacological basis of treatment.
Topics: Amantadine; Analgesics, Opioid; Anticonvulsants; Blood-Brain Barrier; Central Nervous System Disease | 1975 |
[Dopamine beta hydroxylase. Value and limits of its study in neurology].
Topics: Amantadine; Cold Temperature; Dopamine beta-Hydroxylase; Epilepsy; Humans; Levodopa; Movement Disord | 1976 |
[Therapeutic effect of dopaminergic substances in drug-resistant Lennox-Gastaut syndrome].
Topics: Amantadine; Child, Preschool; Epilepsy; Humans; Infant; Levodopa; Syndrome | 1989 |
Attenuation of pentylenetetrazol kindling of epileptogenesis in rats by dopaminergic agents.
Topics: Amantadine; Amphetamine; Animals; Epilepsy; Haloperidol; Kindling, Neurologic; Levodopa; Male; Metoc | 1988 |
[Aminoadamantane therapy in comatose conditions].
Topics: Adult; Aged; Amantadine; Coma; Epilepsy; Female; Hepatic Encephalopathy; Humans; Male; Middle Aged | 1974 |
[Study of the central action of amantadine].
Topics: Amantadine; Animals; Butyrophenones; Central Nervous System; Chlorpromazine; Dihydroxyphenylalanine; | 1971 |
Concurrent session: current trends in neurology and psychiatry.
Topics: Amantadine; Behavior Therapy; Dihydroxyphenylalanine; Epilepsy; Female; Humans; Male; Neurology; Par | 1971 |